Capture is below potential
Prescribing volume exists, but referral destinations, payer restrictions, or pharmacy coverage keep value outside the network.
ElevateRx helps health systems and FQHCs understand where 340B value is being retained, where it is leaking, and which operational moves deserve priority.
Prescribing volume exists, but referral destinations, payer restrictions, or pharmacy coverage keep value outside the network.
Covered entities, owned pharmacies, contract pharmacies, and service lines need to be viewed as one operating footprint without losing entity-level context.
Leadership needs to know whether to optimize the current network, add capacity, pursue designations, or focus on a different opportunity first.
Size specialty and retail opportunity from available prescribing data, with drug, prescriber, site, payer, and destination views where the source supports them.
Compare destination patterns with owned pharmacies and the relevant OPAIS contract-pharmacy roster to identify in-house, contracted, and uncovered opportunity.
Separate headline opportunity from the portion constrained by payer networks, limited distribution, entity type, and other documented assumptions.
Translate analytical gaps into a practical sequence of network, referral, data, and operating actions with explicit assumptions and limitations.
Confirm entity structure, pharmacies, source data, current relationships, and the questions leadership needs answered.
Connect prescribing destinations, reference data, and the pharmacy network while making uncertainty visible.
Identify the moves with the strongest combination of value, feasibility, and operational fit.
Start with the data and program structure you already have. We can identify what is answerable now and what needs better evidence.